Osteoporosis, Bisphosphonates & Dental Implants: MRONJ Risk Screening

If you take bisphosphonate medications for osteoporosis (Fosamax, Boniva, Actonel, Reclast, Prolia), you need to tell your dentist — and your dentist needs to take it seriously. These medications alter bone metabolism in ways that can complicate dental surgery, including implant placement. The condition they can cause — medication-related osteonecrosis of the jaw (MRONJ) — is rare but serious. Proper screening and planning reduce the risk to near zero.

The Concern

Bisphosphonates work by slowing bone resorption — they make bone denser and stronger, which is exactly what you want for osteoporosis. But they also reduce the bone's ability to remodel (the natural process of breaking down old bone and building new bone). When you undergo dental surgery — which relies on bone remodeling to heal extraction sites and integrate implants — reduced remodeling capacity can cause problems.

What Is MRONJ?

Medication-related osteonecrosis of the jaw is a condition where jawbone exposed during dental surgery fails to heal, leading to exposed, necrotic bone that persists for 8+ weeks. It's painful, difficult to treat, and can cause significant jaw damage. The risk is highest with IV bisphosphonates (used for cancer treatment) and lower but present with oral bisphosphonates (used for osteoporosis).

Risk Assessment

Your dentist should assess the specific medication you take (oral vs. IV), how long you've been taking it (risk increases with duration — the 4-year mark is a common clinical threshold), whether you're taking it for osteoporosis vs. cancer (cancer doses are much higher), and additional risk factors (corticosteroid use, diabetes, smoking, chemotherapy).

Safe Treatment Planning

For patients on oral bisphosphonates for less than 4 years with no additional risk factors, most guidelines support proceeding with implant placement using standard protocols. For patients on oral bisphosphonates for more than 4 years, a "drug holiday" (stopping the medication 2–3 months before surgery, with prescribing doctor approval) may be recommended. For patients on IV bisphosphonates, implant placement requires careful risk-benefit discussion — the risk of MRONJ is significantly higher, and alternative restorative options may be safer.

How Colombian Dentists Handle This

Colombian dental clinics that treat international patients screen for bisphosphonate use during the medical-history questionnaire. Disclose all medications — including supplements and over-the-counter drugs — during your consultation. Your Colombian dentist will coordinate with your prescribing physician if a drug holiday is recommended, and will adjust the surgical protocol (minimally invasive technique, antibiotic prophylaxis, close follow-up) to minimize MRONJ risk.

Explore Our Colombia Medical Network